Recombinant Human Thyroid Stimulating Hormone for Radioiodine 131I Treatment

计划入组 30 人 · 首次发布于 2024 年 5 月 8 日

Harmonization of Thyroid-stimulating Hormone Immunoassays Reagents

计划入组 28 人 · 首次发布于 2021 年 12 月 9 日

Safety and Efficacy of Recombinant Human Thyroid Stimulating Hormone for Adjuvant Diagnosis in Patients With Locally Advanced/Metastatic Differentiated Thyroid Cancer

计划入组 15 人 · 首次发布于 2024 年 5 月 28 日

thyroid-stimulating hormone receptor antagonists (NIH)

thyroid-stimulating hormone receptor antagonist (graves disease/thyroid eye disease)

thyroid stimulating hormone

Arvinas Estrogen Receptor, Inc.

United States

Arvinas Androgen Receptor, Inc.

United States

Rare Thyroid Therapeutics International AB

Sweden

GenSci Partners with RTW Investments in $1.365 Billion Deal for First-in-Class Thyroid Autoimmune Disease Therapy

Sling Therapeutics Appoints Andrew Guggenhime to Board as Linsitinib Advances in Phase 2b for TED

VYNE Therapeutics and Yarrow Bioscience Merger Nears Completion: Cash Dividend Distributed, Reverse Stock Split Set, and YB-101 Poised to Advance Autoimmune Thyroid Disease Pipeline